Clinical News and Research

RSS

Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures.

19 Sep 2023

NICER Gene Editing Technique Reduces Unintended Mutations

The gene editing technique CRISPR/Cas9 has allowed researchers to make precise and impactful changes to an organism's DNA to fix mutations that cause genetic disease.

15 Sep 2023

Key Proteins in Human Breast Milk Crucial for Baby’s Healthy Gut

The abundance of two species of bacteria known to be good for human health and used as probiotics, Clostridium butyricum and Parabacteroides distasonis, has been linked to high concentrations of key proteins in human breast milk, particularly osteopontin and κ-casein.

13 Sep 2023

Scientists Uncover New Genetic Insights into Staphylococcus Aureus

New genetic insights into Staphylococcus aureus have been discovered by Australian researchers, showing what makes the bacteria so hazardous when it enters the bloodstream.

13 Sep 2023

African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

13 Sep 2023

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

5 Sep 2023

Largest Genetic Study Discovers Specific DNA Changes That Increase Risk of Epilepsy

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.

5 Sep 2023

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Yourgene Health plc (“Yourgene”), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit. MagBench solution is available to Sage™ customers across Asia-Pacific and the Middle East.

5 Sep 2023

Targeted MicroRNA-34a Therapy Shows Promise in Slowing Tumor Growth in Mice

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

5 Sep 2023

Red Blood Cells May Hold the Key to Preventing Heart Diseases

An innovative KI study published in the Journal of Clinical Investigations found that red blood cells exposed to oxygen deficiency safeguard against myocardial infarction. The research also showed that a nitrate-rich vegetable diet boosts the protective effect.

4 Sep 2023

LJI Scientists Harness 'Helper' T Cells To Treat Tumors

Scientists are on the hunt for a unique set of mutations, called "neoantigens," that let the immune system distinguish tumor cells from normal cells. Their goal is to help the immune system react to neoantigens and target tumor cells for destruction.

4 Sep 2023

The Evolution of Epilepsy and Potential Cure: A New Study

Specific alterations in human DNA have been shown to raise the likelihood of getting epilepsy, according to the biggest genetic study of its type, which was managed by the International League Against Epilepsy and involved researchers from FutureNeuro at RCSI University of Medicine and Health Sciences.

1 Sep 2023

New Gene Therapy Shows Promise in Treating Gliomas

The University of Michigan Department of Neurosurgery and Rogel Cancer Center study demonstrates enticing early results that a therapy merging cell-killing and immune-stimulating drugs is effective and safe in prolonging survival for patients with gliomas, an extremely aggressive form of brain cancer.

1 Sep 2023

Understanding the Role of T Cells in Lung Cancer Could Lead to Improved Immunotherapy Outcomes

Fresh discoveries about a type of immune cells could give lung cancer patients a more accurate prognosis and better identify who will benefit from immunotherapies.

31 Aug 2023

Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities

Bio-Rad Laboratories, Inc. today announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range with 29 additional highly validated antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes.

30 Aug 2023

Genetic Risk of Depression Linked to Increased Risk of Other Psychiatric Disorders

Recent research reveals that people who are hospitalized for depression are at an increased risk of developing conditions like substance abuse, bipolar disorder, schizophrenia, and anxiety, depending on their genetic predisposition to the individual disorder.

30 Aug 2023

NSL Complex Regulates Intraciliary Transport Genes in Multiple Cell Types

The non-specific lethal (NSL) complex is a chromatin-associated factor that has been shown in both fruit flies and mammals to regulate the expression of thousands of genes. Abrogation of the NSL genes causes the organism to die, which gives rise to the complex’s unusual name.

28 Aug 2023

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Thermo Fisher Scientific, the world leader in serving science, today announced the commercial launch of the EXENT® Solution, after receiving IVDR certification.

28 Aug 2023

Case Study Highlights Challenges of Accessing Venom Immunotherapy for Fire Ant Allergies

A recent case study published in the Journal of Allergy and Clinical Immunology: In Practice highlights the challenges faced by families seeking venom immunotherapy for fire ant allergies.

28 Aug 2023

Study Identifies 39 Genetic Mutations Associated With Heart Failure

In a new study co-led by investigators at the United States Department of Veterans Affairs and Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, a global team of scientists conducted one of the largest genetic association studies on heart failure to date.

25 Aug 2023

Clinical News and Research

Broken String Biosciences Closes $15M Series A Funding Round

NICER Gene Editing Technique Reduces Unintended Mutations

Key Proteins in Human Breast Milk Crucial for Baby’s Healthy Gut

Scientists Uncover New Genetic Insights into Staphylococcus Aureus

African BioGenome Project Bridges the Gap in Biodiversity Genomics and Bioinformatics

Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer

Largest Genetic Study Discovers Specific DNA Changes That Increase Risk of Epilepsy

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Targeted MicroRNA-34a Therapy Shows Promise in Slowing Tumor Growth in Mice

Red Blood Cells May Hold the Key to Preventing Heart Diseases

LJI Scientists Harness 'Helper' T Cells To Treat Tumors

The Evolution of Epilepsy and Potential Cure: A New Study

New Gene Therapy Shows Promise in Treating Gliomas

Understanding the Role of T Cells in Lung Cancer Could Lead to Improved Immunotherapy Outcomes

Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities

Genetic Risk of Depression Linked to Increased Risk of Other Psychiatric Disorders

NSL Complex Regulates Intraciliary Transport Genes in Multiple Cell Types

Thermo Fisher Scientific Announces the Launch of the EXENT® Solution with IVDR Certification

Case Study Highlights Challenges of Accessing Venom Immunotherapy for Fire Ant Allergies

Study Identifies 39 Genetic Mutations Associated With Heart Failure

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics